Vitamin B6-dependent epilepsy due to pyridoxal phosphate-binding protein (PLPBP) defect – First case report from Pakistan and review of literature
Open Access
- 1 December 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 60, 721-727
Abstract
The Vitamin B6-dependent epilepsies are a heterogeneous group of autosomal recessive disorders usually characterized by neonatal onset seizures responsive to treatment with vitamin B6 available as pyridoxine (PN) or as the biologically active form pyridoxal 5-phosphate (PLP). The vitamin B6–dependent epilepsies are caused by mutations in at least five different genes involved in B6 metabolism. A literature review revealed that only 30 patients with vitamin B6-dependent epilepsy caused by PLPBP mutation have been reported worldwide. We report a case of baby boy born to first-cousin Pakistani parents who presented with generalized as well as focal seizures starting a few hours after birth and responsive to PLP. Whole exome sequencing revealed a homozygous pathogenic variant NM_007198.4:c.46_47insCA, NP_009129.1:p.Leu17Hisfs, causing a CA duplication resulting in a frameshift in the PLPBP gene. Vitamin B6-Dependent Epilepsy due to PLPBP defect is a rare disorder. The developmental outcomes are variable even with early therapy. Few patients are reported to achieve optimal developmental milestones with therapy. PLP has been advocated as the treatment of choice for PLPBP defect, but oral PN has also demonstrated good seizure control in some patients, including ours. Vitamin B6-dependent epilepsy due to PLPBP defect is an important differential diagnosis to consider in patients with biochemical features suggestive of pyridoxamine 5′-phosphate Oxidase (PNPO) defect and gene testing can facilitate in reaching the correct diagnosis. Prompt diagnosis and treatment led to excellent seizure control in most patients.Keywords
This publication has 10 references indexed in Scilit:
- Diagnostic pitfalls in vitamin B6‐dependent epilepsy caused by mutations in the PLPBP geneJIMD Reports, 2019
- PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insightsBrain, 2019
- PLPBP mutations cause variable phenotypes of developmental and epileptic encephalopathyEpilepsia Open, 2018
- Diagnostic clarity of exome sequencing following negative comprehensive panel testing in the neonatal intensive care unitAmerican Journal of Medical Genetics Part A, 2018
- Confirmation of mutations in PROSC as a novel cause of vitamin B 6 -dependent epilepsyJournal of Medical Genetics, 2017
- Mutations in PROSC Disrupt Cellular Pyridoxal Phosphate Homeostasis and Cause Vitamin-B6-Dependent EpilepsyThe American Journal of Human Genetics, 2016
- Treatable newborn and infant seizures due to inborn errors of metabolismEpileptic Disorders, 2015
- The CARE guidelines: consensus-based clinical case reporting guideline developmentJournal of Medical Case Reports, 2013
- The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein familiesBMC Bioinformatics, 2009
- Cloning and characterization of human and mouse PROSC (proline synthetase co-transcribed) genesJournal of Human Genetics, 1999